Navigation Links
Regeneron Announces June 2012 Investor Conference Presentations
Date:5/30/2012

TARRYTOWN, N.Y., May 30, 2012 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (Nasdaq: REGN) will webcast management presentations at the following investor conferences:

  • Goldman Sachs Global Healthcare Conference 2012 at 7:00 p.m. Eastern Time (4:00 p.m. Pacific Time) on Tuesday, June 5, 2012
  • Jefferies 2012 Global Healthcare Conference at 10:30 a.m. Eastern Time on Thursday, June 7, 2012
  • The sessions may be accessed through the Company's web site, www.regeneron.com, on the 'Events and Presentations' page.  Archived versions of the presentations will be available for thirty days after the live webcasts. 

    Regeneron is a fully integrated biopharmaceutical company that discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions.  Regeneron markets two products in the United States, ARCALYST® (rilonacept) Injection for Subcutaneous Use and EYLEA® (aflibercept) Injection, and has filed regulatory applications with the U.S. Food and Drug Administration (FDA) for second indications for each of these products.   A regulatory application has also been submitted to the FDA for the product candidate ZALTRAP® (aflibercept) Concentrate for Intravenous Infusion.  Phase 3 studies are in progress with EYLEA® in a third indication, and with product candidate sarilumab.  Earlier-stage clinical programs are underway with nine additional monoclonal antibodies.  Regeneron has active research and development programs in many disease areas, including ophthalmology, inflammation, cancer, and hypercholesterolemia.  Additional information and recent news releases are available on the Regeneron web site at www.regeneron.com.Contact Information: Manisha Narasimhan, Ph.D.

    Peter DworkinInvestor Relations

    Corporate Communications914-847-5126

    914-847-764manisha.narasimhan@regeneron.com 

    peter.dworkin@regeneron.com


    '/>"/>
    SOURCE Regeneron Pharmaceuticals, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Related medicine technology :

    1. Regeneron Provides Update On FDA Advisory Committee Discussion of ARCALYST® (rilonacept) Injection
    2. Regeneron and Bayer Announce Co-Promotion Agreement With Santen For EYLEA® (aflibercept) Injection in Japan
    3. Regeneron to Report First Quarter 2012 Financial and Operating Results and Host Conference Call and Webcast on April 26, 2012
    4. Regeneron Announces Data Publication and Presentations with Potential First-in-Class Lipid-Lowering PCSK9 Antibody
    5. Regeneron Announces February 2012 Investor Conference Presentations
    6. Regeneron to Report Full Year 2011 Financial and Operating Results and Host Conference Call and Webcast on February 16, 2012
    7. Regeneron Announces Settlement of Patent Litigation with Genentech for U.S. Ophthalmic Sales of EYLEA™ (aflibercept) Injection
    8. Regeneron to Host Conference Call on January 3 at 8:30 a.m. Eastern Time to Discuss Ongoing Patent Litigation
    9. Regeneron Announces Presentation Time Change at the 2011 Deutsche Bank BioFEST
    10. Regeneron Announces FDA Acceptance of ARCALYST® (rilonacept) Supplemental Biologics License Application for Review
    11. Rockefeller University President Marc Tessier-Lavigne Elected to Regeneron Board of Directors
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:5/30/2020)... ... , ... HealthyChildren.org, the official parenting website of the American Academy of Pediatrics ... lucky winners will receive a $200 Amazon.com* gift card. The contest begins June 15 ... day during the event. Winners will be drawn on or about June 22, 2020. ...
    (Date:5/30/2020)... ... , ... During a crisis, the platitude “stay strong” is well-intended, but difficult ... and strengthened through hardship. Recent research conducted by PsychTests.com reveals that mentally ... order to stay strong in the face of adversity. It seems that resilience isn’t ...
    (Date:5/28/2020)... ... May 28, 2020 , ... Deborah Heart and ... Alliance member of the Cleveland Clinic Heart, Vascular & Thoracic Institute, has announced ... disease (COPD). , COPD is a growing and devastating disease and is the ...
    Breaking Medicine Technology:
    (Date:5/30/2020)... ... ... with kathy ireland® will be LIVE streaming this week’s episode of their ... ET / PT – two chances to watch each night! This episode’s exclusive interviews will ... Laboratory . , As leaders in their industries, these three companies demonstrate ...
    (Date:5/30/2020)... Calif. (PRWEB) , ... May 30, 2020 , ... ... with advanced technology and virtual solutions that can meet the needs of a ... , HashCash’s healthcare solutions abide by the necessary compliances and augment ...
    (Date:5/28/2020)... ... 2020 , ... With a growing number of colleges and ... are scrambling to implement practices that will help reduce residents’ risk of getting ... 38 campuses across the country, has researched best practices and identified solutions to ...
    (Date:5/27/2020)... ... May 27, 2020 , ... Radiology Associates ... the United States, has aligned with the Strategic Radiology (SR) coalition of independent ... to join the SR coalition, which has 28 member practices in 20 different ...
    (Date:5/26/2020)... ... May 26, 2020 , ... ... two leading RevSpring solutions—Talksoft® patient messaging and IVR Advantage™--for Loyale customers. Talksoft ... through automated and precise texts, IVR reminders and email messages tailored to ...
    Breaking Medicine News(10 mins):